Sandoz Can't Void Rival's Patent For Narcolepsy Drug Sunosi
A European appeals panel has rejected Sandoz's latest attempt to void rival company Axsome's patent for narcolepsy drug Sunosi, ruling that the immediate-release version of the drug is inventive enough to...To view the full article, register now.
Already a subscriber? Click here to view full article